Đang chuẩn bị liên kết để tải về tài liệu:
Predictive value of prognostic nutritional index (PNI) in recurrent or unresectable hepatocellular carcinoma received anti-PD1 therapy

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

Clinical trials have shown that anti-PD1 therapy, either as a monotherapy or in combination, is effective and well-tolerated in patients with recurrent or unresectable hepatocellular carcinoma (HCC). In this study, we aimed to investigate the prognostic value of immune-nutritional biomarkers in measuring the effects of anti-PD1 therapy in these patients. |

TÀI LIỆU LIÊN QUAN

Neutrophil/Lymphocyte ratio has no predictive or prognostic value in breast cancer patients undergoing preoperative systemic therapy

The prognostic value of the Tau protein serum level in metastatic breast cancer patients and its correlation with brain metastases

Prognostic and predictive value of cathepsin X in serum from colorectal cancer patients

A predictive and prognostic model for hepatocellular carcinoma with microvascular invasion based TCGA database genomics

Predictive and prognostic value of Matrix metalloproteinase (MMP) - 9 in neoadjuvant chemotherapy for triplenegative breast cancer patients

Predictive and prognostic value of PET/CT imaging post-chemoradiotherapy and clinical decision-making consequences in locally advanced head & neck squamous cell carcinoma: A retrospective study

Early venous thromboembolism at the beginning of palliative chemotherapy is a poor prognostic factor in patients with metastatic pancreatic cancer: A retrospective study

The prognostic and predictive value of tumor-infiltrating lymphocytes and hematologic parameters in patients with breast cancer

Evaluation of public cancer datasets and signatures identifies TP53 mutant signatures with robust prognostic and predictive value

The prognostic and predictive value of ESR1 fusion gene transcripts in primary breast cancer